ADENOSINE Drug Patent Profile
✉ Email this page to a colleague
When do Adenosine patents expire, and when can generic versions of Adenosine launch?
Adenosine is a drug marketed by Am Regent, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Mylan Labs Ltd, Rising, Teva Pharms Usa, Wockhardt, Avet Lifesciences, Eugia Pharma, Hospira, Meitheal, and Mylan Asi. and is included in twenty-one NDAs.
The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adenosine
A generic version of ADENOSINE was approved as adenosine by HIKMA on June 16th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ADENOSINE?
- What are the global sales for ADENOSINE?
- What is Average Wholesale Price for ADENOSINE?
Summary for ADENOSINE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 21 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 161 |
| Clinical Trials: | 610 |
| Drug Prices: | Drug price information for ADENOSINE |
| DailyMed Link: | ADENOSINE at DailyMed |
Recent Clinical Trials for ADENOSINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| MedSIR | Phase 2 |
| Society of Cardiovascular Anesthesiologists | Phase 4 |
| The University of Texas Health Science Center, Houston | Phase 4 |
Pharmacology for ADENOSINE
| Drug Class | Adenosine Receptor Agonist |
| Mechanism of Action | Adenosine Receptor Agonists |
Medical Subject Heading (MeSH) Categories for ADENOSINE
Anatomical Therapeutic Chemical (ATC) Classes for ADENOSINE
US Patents and Regulatory Information for ADENOSINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 090450-002 | Oct 2, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Am Regent | ADENOSINE | adenosine | INJECTABLE;INJECTION | 090010-001 | Apr 28, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 205331-002 | Nov 2, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Meitheal | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 077425-002 | Aug 29, 2013 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
